{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Execution of Cox model\n",
    "\n",
    "In this notebook, we test the Cox model for the data from the following article : https://doi.org/10.1158/1078-0432.CCR-20-1163."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from survivalAnalysis.CoxModel import CoxModel\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Reading and preprocessing\n",
    "\n",
    "We read the ```data/Supplemental-table1.xlsx``` file, and we drop the non-naive patients from the dataframe."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Anonymous ID</th>\n",
       "      <th>EGA ID</th>\n",
       "      <th>Tumour type</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Line of therapy</th>\n",
       "      <th>Immunotherapy regimen</th>\n",
       "      <th>Cohort</th>\n",
       "      <th>Reason for discontinuation</th>\n",
       "      <th>Best response</th>\n",
       "      <th>Age at advanced disease diagnosis</th>\n",
       "      <th>...</th>\n",
       "      <th>Alive_0</th>\n",
       "      <th>Time to progression (days)</th>\n",
       "      <th>Progression_1</th>\n",
       "      <th>Clinical benefit</th>\n",
       "      <th>CD8+ T cell score</th>\n",
       "      <th>Exome mut per mb</th>\n",
       "      <th>Genome mut per mb</th>\n",
       "      <th>CD274 expression</th>\n",
       "      <th>M1M2 expression</th>\n",
       "      <th>Lymph related</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>14891</td>\n",
       "      <td>EGAD00001001961</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>8</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Mixed</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>179</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.351869</td>\n",
       "      <td>11.095310</td>\n",
       "      <td>23.0729</td>\n",
       "      <td>4.1689</td>\n",
       "      <td>55.51575</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>18624</td>\n",
       "      <td>EGAD00001002047</td>\n",
       "      <td>AECA</td>\n",
       "      <td>F</td>\n",
       "      <td>10</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>148</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.071464</td>\n",
       "      <td>3.876336</td>\n",
       "      <td>5.4552</td>\n",
       "      <td>0.7910</td>\n",
       "      <td>9.32352</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21392</td>\n",
       "      <td>EGAD00001002544</td>\n",
       "      <td>OV</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>79</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.040394</td>\n",
       "      <td>2.415688</td>\n",
       "      <td>4.1274</td>\n",
       "      <td>4.0377</td>\n",
       "      <td>50.12008</td>\n",
       "      <td>Lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>21516</td>\n",
       "      <td>EGAD00001002546</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Ipilimumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>29</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.052774</td>\n",
       "      <td>6.235845</td>\n",
       "      <td>11.4871</td>\n",
       "      <td>0.6006</td>\n",
       "      <td>1.58550</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>22186</td>\n",
       "      <td>EGAD00001001966</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>52</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>80</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.009323</td>\n",
       "      <td>4.606660</td>\n",
       "      <td>7.1503</td>\n",
       "      <td>1.8234</td>\n",
       "      <td>38.42695</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>39280</td>\n",
       "      <td>EGAD00001004933</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Physician Assessed SD</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>401</td>\n",
       "      <td>0</td>\n",
       "      <td>DCB</td>\n",
       "      <td>0.695396</td>\n",
       "      <td>84.998501</td>\n",
       "      <td>96.4079</td>\n",
       "      <td>8.4768</td>\n",
       "      <td>86.62561</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>37899</td>\n",
       "      <td>EGAD00001005838</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>F</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>38</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>96</td>\n",
       "      <td>0</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.818233</td>\n",
       "      <td>2.247151</td>\n",
       "      <td>2.7416</td>\n",
       "      <td>11.2704</td>\n",
       "      <td>47.97376</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>37775</td>\n",
       "      <td>EGAD00001004934</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Avelumab/OX40 agonist PF-04518600</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>69</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>69</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.018982</td>\n",
       "      <td>3.848247</td>\n",
       "      <td>5.8036</td>\n",
       "      <td>8.7136</td>\n",
       "      <td>5.13403</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>38313</td>\n",
       "      <td>EGAD00001005844</td>\n",
       "      <td>ACC</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Avelumab/Debio1143 (SMAC mimetic)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Partial response</td>\n",
       "      <td>34</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>51</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.617878</td>\n",
       "      <td>7.7940</td>\n",
       "      <td>0.0688</td>\n",
       "      <td>0.51364</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>38207</td>\n",
       "      <td>EGAD00001005850</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>50</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>104</td>\n",
       "      <td>1</td>\n",
       "      <td>NCB</td>\n",
       "      <td>0.110416</td>\n",
       "      <td>33.763449</td>\n",
       "      <td>53.2769</td>\n",
       "      <td>23.8818</td>\n",
       "      <td>11.22022</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>82 rows Ã— 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Anonymous ID           EGA ID Tumour type Sex Line of therapy   \n",
       "0          14891  EGAD00001001961        LUNG   F               8  \\\n",
       "1          18624  EGAD00001002047        AECA   F              10   \n",
       "2          21392  EGAD00001002544          OV   F               6   \n",
       "3          21516  EGAD00001002546        SKCM   F               3   \n",
       "4          22186  EGAD00001001966        LUNG   F               4   \n",
       "..           ...              ...         ...  ..             ...   \n",
       "92         39280  EGAD00001004933        LUNG   M               2   \n",
       "94         37899  EGAD00001005838        CHOL   F               2   \n",
       "95         37775  EGAD00001004934        HNSC   M               1   \n",
       "96         38313  EGAD00001005844         ACC   F               3   \n",
       "97         38207  EGAD00001005850        LUNG   F               1   \n",
       "\n",
       "                Immunotherapy regimen Cohort Reason for discontinuation   \n",
       "0                           Nivolumab  Naive                Progression  \\\n",
       "1                           Nivolumab  Naive                Progression   \n",
       "2                         Monalizumab  Naive                Progression   \n",
       "3                          Ipilimumab  Naive                      Death   \n",
       "4                        Atezolizumab  Naive                Progression   \n",
       "..                                ...    ...                        ...   \n",
       "92                      Pembrolizumab  Naive                   Toxicity   \n",
       "94                          Nivolumab  Naive                      Death   \n",
       "95  Avelumab/OX40 agonist PF-04518600  Naive                Progression   \n",
       "96  Avelumab/Debio1143 (SMAC mimetic)  Naive                   Toxicity   \n",
       "97                      Pembrolizumab  Naive                Progression   \n",
       "\n",
       "            Best response  Age at advanced disease diagnosis  ...  Alive_0   \n",
       "0                   Mixed                                 45  ...        1  \\\n",
       "1          Stable disease                                 47  ...        1   \n",
       "2   Physician assessed SD                                 57  ...        1   \n",
       "3           Not evaluable                                 29  ...        1   \n",
       "4          Stable disease                                 52  ...        1   \n",
       "..                    ...                                ...  ...      ...   \n",
       "92  Physician Assessed SD                                 60  ...        1   \n",
       "94  Physician assessed PR                                 38  ...        1   \n",
       "95         Stable disease                                 69  ...        1   \n",
       "96       Partial response                                 34  ...        1   \n",
       "97  Physician assessed SD                                 50  ...        0   \n",
       "\n",
       "    Time to progression (days)  Progression_1  Clinical benefit   \n",
       "0                          179              1               NCB  \\\n",
       "1                          148              1               NCB   \n",
       "2                           79              1               NCB   \n",
       "3                           11              0               NCB   \n",
       "4                           80              1               NCB   \n",
       "..                         ...            ...               ...   \n",
       "92                         401              0               DCB   \n",
       "94                          96              0               NCB   \n",
       "95                          69              1               NCB   \n",
       "96                          51              1               NCB   \n",
       "97                         104              1               NCB   \n",
       "\n",
       "   CD8+ T cell score  Exome mut per mb  Genome mut per mb  CD274 expression   \n",
       "0           0.351869         11.095310            23.0729            4.1689  \\\n",
       "1           0.071464          3.876336             5.4552            0.7910   \n",
       "2           0.040394          2.415688             4.1274            4.0377   \n",
       "3           0.052774          6.235845            11.4871            0.6006   \n",
       "4           0.009323          4.606660             7.1503            1.8234   \n",
       "..               ...               ...                ...               ...   \n",
       "92          0.695396         84.998501            96.4079            8.4768   \n",
       "94          0.818233          2.247151             2.7416           11.2704   \n",
       "95          0.018982          3.848247             5.8036            8.7136   \n",
       "96          0.000000          5.617878             7.7940            0.0688   \n",
       "97          0.110416         33.763449            53.2769           23.8818   \n",
       "\n",
       "    M1M2 expression      Lymph related  \n",
       "0          55.51575  Non-lymph related  \n",
       "1           9.32352  Non-lymph related  \n",
       "2          50.12008      Lymph related  \n",
       "3           1.58550  Non-lymph related  \n",
       "4          38.42695  Non-lymph related  \n",
       "..              ...                ...  \n",
       "92         86.62561  Non-lymph related  \n",
       "94         47.97376  Non-lymph related  \n",
       "95          5.13403  Non-lymph related  \n",
       "96          0.51364  Non-lymph related  \n",
       "97         11.22022  Non-lymph related  \n",
       "\n",
       "[82 rows x 21 columns]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('data/Supplemental-table1.xlsx')\n",
    "df = df.loc[df[\"Cohort\"] == \"Naive\"]\n",
    "df"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Determine the risk class for each using Cox regression and survival curves\n",
    "\n",
    "With the ```CoxModel``` class implementing a Cox Regression, we can determine the risk class for each sample : high (class 1) or low (class 0). Because we have few data, we use a **leave one out cross validation**, which consists in fitting the model with all the dataset except 1 sample, then we predict the risk class for the test sample."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "coxmodel = CoxModel()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### TTP (Time To Progression) event\n",
    "Here, the event is the disease has progressed. So we measure the risk of the disease to progress."
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Finding risk classes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([0., 1., 0., 0., 1., 0., 1., 0., 1., 1., 0., 1., 1., 0., 0., 1., 0.,\n",
       "       0., 1., 1., 1., 0., 0., 0., 1., 0., 1., 0., 1., 1., 0., 1., 1., 1.,\n",
       "       1., 0., 0., 0., 1., 0., 0., 1., 1., 1., 0., 0., 0., 1., 0., 0., 0.,\n",
       "       1., 1., 1., 1., 1., 0., 1., 1., 0., 1., 1., 1., 0., 1., 1., 0., 1.,\n",
       "       0., 1., 1., 0., 1., 0., 0., 0., 0., 1., 0., 0., 1., 0.])"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Preprocessing for the label data\n",
    "X_ttp = df.loc[:,[\"CD8+ T cell score\",\"Exome mut per mb\",\"Genome mut per mb\",\"CD274 expression\",\"M1M2 expression\"]].to_numpy()\n",
    "y_ttp = np.array(list((df[['Progression_1','Time to progression (days)']].itertuples(index=False, name=None))),dtype=[('Progression_1', '?'), ('Time to progression (days)', '<f8')])\n",
    "\n",
    "# Finding the risk classes\n",
    "risk_classes_ttp = coxmodel.leave_one_out_cross_validation(X_ttp,y_ttp)\n",
    "risk_classes_ttp"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Determining the survival curves\n",
    "With the Cox model, we have the survival probability for each sample along time. So we compute the mean survival curve from these curves."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Split the data in high risk group and low risk group\n",
    "high_risk_ttp = X_ttp[np.where(risk_classes_ttp==1)]\n",
    "low_risk_ttp = X_ttp[np.where(risk_classes_ttp==0)]\n",
    "\n",
    "# Compute the mean survival curves for each group\n",
    "high_risk_event_times_ttp, high_risk_survival_curve_ttp = coxmodel.predict_mean_survival_curve(high_risk_ttp)\n",
    "low_risk_event_times_ttp, low_risk_survival_curve_ttp = coxmodel.predict_mean_survival_curve(low_risk_ttp)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### OS (Overall survival) event\n",
    "Here, the event is the patient has died. So we measure the risk of death."
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Finding the risk classes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([0., 0., 1., 0., 1., 0., 1., 0., 1., 1., 0., 1., 1., 0., 0., 1., 1.,\n",
       "       0., 1., 1., 0., 0., 0., 0., 1., 0., 1., 0., 1., 1., 0., 1., 1., 1.,\n",
       "       1., 0., 0., 0., 1., 0., 1., 1., 1., 1., 0., 0., 0., 1., 0., 0., 0.,\n",
       "       1., 1., 1., 1., 1., 0., 1., 1., 0., 0., 1., 0., 0., 1., 1., 1., 1.,\n",
       "       1., 0., 1., 0., 1., 0., 0., 0., 0., 1., 0., 0., 1., 0.])"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Preprocessing for the label data\n",
    "X_os = df.loc[:,[\"CD8+ T cell score\",\"Exome mut per mb\",\"Genome mut per mb\",\"CD274 expression\",\"M1M2 expression\"]].to_numpy()\n",
    "y_os = np.array(list((df[['Alive_0','Overall survival (days)']].itertuples(index=False, name=None))),dtype=[('Alive_0', '?'), ('Overall survival (days)', '<f8')])\n",
    "\n",
    "# Finding the risk classes\n",
    "risk_classes_os = coxmodel.leave_one_out_cross_validation(X_os,y_os)\n",
    "risk_classes_os"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Determining the survival curves"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Split the data in high risk group and low risk group\n",
    "high_risk_os = X_os[np.where(risk_classes_os==1)]\n",
    "low_risk_os = X_os[np.where(risk_classes_os==0)]\n",
    "\n",
    "# Compute the mean survival curves for each group\n",
    "high_risk_event_times_os, high_risk_survival_curve_os = coxmodel.predict_mean_survival_curve(high_risk_os)\n",
    "low_risk_event_times_os, low_risk_survival_curve_os = coxmodel.predict_mean_survival_curve(low_risk_os)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Plot the survival curves\n",
    "Now, we want to plot the survival curves for each class (high and low). Ideally, the curves should be very different."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x700 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots(1,2,figsize=(15,7))\n",
    "\n",
    "# TTP : \n",
    "ax[0].step(low_risk_event_times_ttp, low_risk_survival_curve_ttp, where='post',color='blue',label='low risk')\n",
    "ax[0].step(high_risk_event_times_ttp, high_risk_survival_curve_ttp, where='post',color='red',label='high risk')\n",
    "ax[0].set_xlabel('Time (days)')\n",
    "ax[0].set_ylabel('Proportion without progression')\n",
    "ax[0].set_title('TTP along time (progression risk)')\n",
    "#ax[0].text(0,0,f'p value : {p_value_cd274_ttp}')\n",
    "\n",
    "# OS : \n",
    "ax[1].step(low_risk_event_times_os, low_risk_survival_curve_os, where='post',color='blue',label='low risk')\n",
    "ax[1].step(high_risk_event_times_os, high_risk_survival_curve_os, where='post',color='red',label='high risk')\n",
    "ax[1].set_xlabel('Time (days)')\n",
    "ax[1].set_ylabel('Proportion surviving')\n",
    "ax[1].set_title('OS along time (death risk)')\n",
    "#ax[0].text(0,0,f'p value : {p_value_cd274_ttp}')\n",
    "\n",
    "plt.legend()\n",
    "plt.savefig('figures/survival-curves.png')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
